S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

Completed · Phase 2

Conditions studied: Gastrointestinal Stromal Tumor

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have unresectable or metastatic gastrointestinal stromal tumors.

Key facts

Study ID
NCT00005597
Run by
SWOG Cancer Research Network
People needed
25
Starts
2000-04-01
Expected to finish
2005-10-01
Last updated by the study team
2013-01-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.